Mometasone Teva (Mometasone Furoate)

Mometasone furoate acts as an agonist at glucocorticoid receptors within nasal mucosal cells. By binding these receptors, it suppresses the transcription of inflammatory genes, decreasing the production of cytokines, chemokines, and other mediators that cause swelling and irritation in the nasal passages.

The specific dose and frequency of Mometasone Teva are determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and not alter the regimen without medical advice.

Safety data for mometasone furoate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mometasone Teva.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mometasone Teva contains mometasone furoate, which is a high‑potency, once‑daily corticosteroid with minimal systemic absorption. Compared with older agents such as fluticasone or budesonide, mometasone often provides comparable or superior symptom control with a similar safety profile when used as directed.

Mometasone Teva should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain its stability and efficacy.

The medication is delivered as a nasal spray. The patient tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of actuations while breathing in gently. The same procedure is repeated in the other nostril if required.

Serious adverse events, though rare, can include nasal septal perforation, severe allergic reactions (anaphylaxis), adrenal suppression with prolonged use, and opportunistic fungal infections of the nasal cavity. Any signs of these conditions should prompt immediate medical evaluation.

Mometasone Teva is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated nasal infections or recent nasal surgery unless directed by a physician.